China Lilang Ltd
F:5LX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Lilang Ltd
F:5LX
|
CN |
|
E
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
|
S
|
SI-BONE Inc
F:2K3
|
US |
|
F
|
Fielmann Group AG
XMUN:FIE
|
DE |
|
Dufry AG
F:D2J
|
CH |
|
V
|
Vallourec SA
LSE:0NR2
|
FR |
|
M
|
Medallion Financial Corp
F:MD5
|
US |
|
Verallia SA
PAR:VRLA
|
FR |
Wall St Price Targets
5LX Price Targets Summary
China Lilang Ltd
According to Wall Street analysts, the average 1-year price target for 5LX is 0.32 EUR with a low forecast of 0.32 EUR and a high forecast of 0.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5LX's stock price target?
Price Target
0.32
EUR
According to Wall Street analysts, the average 1-year price target for 5LX is 0.32 EUR with a low forecast of 0.32 EUR and a high forecast of 0.33 EUR.
What is the Revenue forecast for China Lilang Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is 8%.
What is the Operating Income forecast for China Lilang Ltd?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is 14%.
What is the Net Income forecast for China Lilang Ltd?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 2 years is 11%.
